Cancer Trials Ireland Dublin 11, Ireland
Cancer Trials Ireland
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Cancer Trials Ireland Dublin 11, Ireland as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:37 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT04042051 · Copanlisib in Combination With T-DM1 in Pretreated Unresectable Locally Advanced or Metastatic HER2-positive Breast CancerCancer Trials Ireland · terminated · HER2-positive Breast Cancer, Metastatic Breast Cancer, Locally Advanced Breast Cancer · study director
- Ph1NCT03153280 · Dose Escalation Study of Lithium With Oxaliplatin and Capecitabine in Advanced Oesophago-Gastric or Colorectal CancerCancer Trials Ireland · terminated · Colorectal Neoplasms, Stomach Neoplasm, Esophageal Neoplasms · study director
- Ph1NCT02705859 · Phase Ib/II Trial of coPANlisib in Combination With Trastuzumab in HER2-positive Breast Cancer. (Panther Study)Cancer Trials Ireland · completed · HER2 Positive Breast Cancer · study director
- N/ANCT00911716 · TC Avastin. ICORG 08-10, V6Cancer Trials Ireland · completed · Breast Cancer · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:37 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in breast cancer.